<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04602026</url>
  </required_header>
  <id_info>
    <org_study_id>OSU-20057</org_study_id>
    <secondary_id>NCI-2020-04925</secondary_id>
    <secondary_id>P30CA016058</secondary_id>
    <nct_id>NCT04602026</nct_id>
  </id_info>
  <brief_title>Re-Defining Frailty and Improving Outcomes Through Prehabilitation in Patients With Pancreatic, Liver, or Gastric Cancer, The RIOT Trial</brief_title>
  <acronym>RIOT</acronym>
  <official_title>Re-Defining Frailty and Improving Outcomes Through Prehabilitation (RIOT Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University Comprehensive Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio State University Comprehensive Cancer Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial studies how well a prehabilitation program works to improve patient outcomes after&#xD;
      surgery compared to the normal standard of care prehabilitation in frail patients undergoing&#xD;
      surgery for pancreatic, liver, or gastric cancer. Frailty is defined as the pathophysiology&#xD;
      of aging or through the accumulation of physiologic and functional deficits. Prehabilitation&#xD;
      programs seek to optimize the medical and physical state of patients prior to undergoing&#xD;
      surgery with the goal of improving outcomes following surgery. Despite evidence for its&#xD;
      importance in health outcomes for frail patients, prehabilitation programs have not been well&#xD;
      studied in cancer surgery populations. This trial may provide researchers with more&#xD;
      information on how to improve patient outcomes after cancer surgery through the use of&#xD;
      prehabilitation programs.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVES:&#xD;
&#xD;
      I. To develop a novel, multi-dimensional index of physiologic reserve and resilience specific&#xD;
      to surgical cancer patients.&#xD;
&#xD;
      II. To implement and assess a novel comprehensive multidimensional prehabilitation program on&#xD;
      frail cancer surgery patients.&#xD;
&#xD;
      OUTLINE: Non-frail patients are assigned to Arm 1. Frail patients are randomized to Arms 2 or&#xD;
      3.&#xD;
&#xD;
      ARM I: Non-frail patients receive standard of care.&#xD;
&#xD;
      ARM II: Frail patients receive standard of care.&#xD;
&#xD;
      ARM III: Frail patients undergo a physical therapy consultation and complete home exercises 3&#xD;
      days per week.&#xD;
&#xD;
      After completion of study treatment, patients are followed up at 2 weeks after surgery and&#xD;
      then every 3 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 14, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frailty assessment</measure>
    <time_frame>Baseline</time_frame>
    <description>A rapid assessment for frailty using the widely used 5-item fatigue, resistance, ambulation, illness, &amp; loss of weight (FRAIL) questionnaire will be performed. Patients are identified as frail by scoring 2 or more points on the FRAIL questionnaire. The frailty assessment will be aimed at identifying factors related to the 6 characteristics of frailty: physical performance, gait speed, mobility, nutritional status, mental health and cognition.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Morbidity</measure>
    <time_frame>Baseline</time_frame>
    <description>Will be assessed using standardized case report forms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complication burden</measure>
    <time_frame>Baseline</time_frame>
    <description>Will be calculated using the Comprehensive Complication Index (CCI). This method is more powerful than standard binary measures of morbidity (presence/absence of individual events) as it presents a quantitative score based on an aggregate weighted total ranging from 0 (no complications) to 100 (death).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Health-related quality of life (composite measure)</measure>
    <time_frame>Baseline, 2 weeks, 3, 6, 12 months</time_frame>
    <description>Will be recorded by administration of the Patient Reported Outcomes Measurement Information System (PROMIS) health-related quality of life questionnaire. PROMIS is a validated set of patient-centered measures that evaluates and monitors life domains (physical, mental, social health) and provide standardized patient reported outcome resources for use in clinical research and practice.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Adult Liver Carcinoma</condition>
  <condition>Gastric Carcinoma</condition>
  <condition>Malignant Solid Neoplasm</condition>
  <condition>Pancreatic Carcinoma</condition>
  <arm_group>
    <arm_group_label>Arm I (best practice)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Non-frail patients receive standard of care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm II (best practice)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Frail patients receive standard of care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm III (physical therapy consultation, exercise intervention)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Frail patients undergo a physical therapy consultation and complete home exercises 3 days per week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Best Practice</intervention_name>
    <description>Receive standard of care</description>
    <arm_group_label>Arm I (best practice)</arm_group_label>
    <arm_group_label>Arm II (best practice)</arm_group_label>
    <other_name>standard of care</other_name>
    <other_name>standard therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise Intervention</intervention_name>
    <description>Complete home exercise intervention</description>
    <arm_group_label>Arm III (physical therapy consultation, exercise intervention)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Physical Therapy</intervention_name>
    <description>Undergo physical therapy</description>
    <arm_group_label>Arm III (physical therapy consultation, exercise intervention)</arm_group_label>
    <other_name>Physiatric Procedure</other_name>
    <other_name>Physical Medicine Procedure</other_name>
    <other_name>Physical Therapeutics</other_name>
    <other_name>Physical Therapy Procedure</other_name>
    <other_name>Physiotherapy</other_name>
    <other_name>Physiotherapy Procedure</other_name>
    <other_name>PT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm I (best practice)</arm_group_label>
    <arm_group_label>Arm II (best practice)</arm_group_label>
    <arm_group_label>Arm III (physical therapy consultation, exercise intervention)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Scheduled for pancreatic, liver or gastric cancer surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non-English speaking&#xD;
&#xD;
          -  Prisoners&#xD;
&#xD;
          -  Persons unable to provide informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aslam Ejaz, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University Comprehensive Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>The Ohio State University Comprehensive Cancer Center</last_name>
    <phone>800-293-5066</phone>
    <email>OSUCCCClinicaltrials@osumc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aslam Ejaz, MD, MPH</last_name>
    <phone>614-293-7171</phone>
    <email>Aslam.Ejaz@osum.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ohio State University Comprehensive Cancer Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aslam Ejaz, MD, MPH</last_name>
      <phone>614-293-7171</phone>
      <email>Aslam.Ejaz@osum.edu</email>
    </contact>
    <investigator>
      <last_name>Aslam Ejaz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://cancer.osu.edu</url>
    <description>The Jamesline</description>
  </link>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 20, 2020</study_first_submitted>
  <study_first_submitted_qc>October 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2020</study_first_posted>
  <last_update_submitted>October 24, 2020</last_update_submitted>
  <last_update_submitted_qc>October 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University Comprehensive Cancer Center</investigator_affiliation>
    <investigator_full_name>Aslam Ejaz</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
    <mesh_term>Frailty</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coal Tar</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

